Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 21962402)

Published in Atherosclerosis on September 16, 2011

Authors

Sebastien Saliques1, Jean-Raymond Teyssier, Catherine Vergely, Luc Lorgis, Julie Lorin, Michel Farnier, Anne Donzel, Pierre Sicard, Juliane Berchoud, Anne-Cécile Lagrost, Claude Touzery, Sylviane Ragot, Yves Cottin, Luc Rochette, Marianne Zeller

Author Affiliations

1: IFR Santé-STIC, Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaires Expérimentales, UFR Médecine, Université de Bourgogne EA2979, Dijon, France.

Articles citing this

Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev (2015) 1.05

Neighborhood characteristics and leukocyte telomere length: the Multi-Ethnic Study of Atherosclerosis. Health Place (2014) 0.90

Telomeres and atherosclerosis. Cardiovasc J Afr (2012) 0.89

TERT's role in colorectal carcinogenesis. Mol Carcinog (2012) 0.86

Perceived stress and telomere length: A systematic review, meta-analysis, and methodologic considerations for advancing the field. Brain Behav Immun (2016) 0.82

Up-regulation of leucocytes genes implicated in telomere dysfunction and cellular senescence correlates with depression and anxiety severity scores. PLoS One (2012) 0.81

Cord blood telomere length in Latino infants: relation with maternal education and infant sex. J Perinatol (2015) 0.78

Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study. Aging (Albany NY) (2016) 0.77

Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome. PLoS One (2015) 0.76

Early exclusive breastfeeding is associated with longer telomeres in Latino preschool children. Am J Clin Nutr (2016) 0.76

Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases. Front Pharmacol (2016) 0.75

Simultaneous Bilateral Carotid Stenting for Symptomatic Bilateral High-Grade Carotid Stenosis: A Retrospective Clinical Investigation. Med Sci Monit (2016) 0.75

Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series. J Am Coll Cardiol (2017) 0.75

Articles by these authors

International network of cancer genome projects. Nature (2010) 20.35

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet (2003) 11.67

Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med (2015) 5.59

Postconditioning the human heart. Circulation (2005) 4.35

Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular Project (DIVA). Heart (2010) 2.83

Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61

Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50

Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation (2008) 2.33

Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort. Circulation (2014) 2.21

Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation (2008) 2.02

Takotsubo Cardiomyopathy Following Acute Cerebral Events. Eur Neurol (2015) 1.98

Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure. Eur Heart J (2005) 1.72

Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction. J Clin Endocrinol Metab (2010) 1.68

High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction. J Am Coll Cardiol (2007) 1.56

Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction. Heart Lung (2013) 1.53

Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol (2015) 1.52

After four hours of cold ischemia and cardioplegic protocol, the heart can still be rescued with postconditioning. Transplantation (2007) 1.51

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circ Cardiovasc Genet (2015) 1.50

Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol (2002) 1.49

Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome). JACC Cardiovasc Interv (2012) 1.47

Prognostic value of ST-segment resolution after rescue percutaneous coronary intervention. Data from the RICO survey. Catheter Cardiovasc Interv (2008) 1.37

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging (2007) 1.33

Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med (2005) 1.33

French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart (2012) 1.31

Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther (2013) 1.28

Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology (2002) 1.20

Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20

Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis. Mol Cell Proteomics (2009) 1.18

Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med (2004) 1.15

Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies. Cardiovasc Drugs Ther (2014) 1.15

Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction. Arterioscler Thromb Vasc Biol (2008) 1.10

Postnatal overfeeding in rodents by litter size reduction induces major short- and long-term pathophysiological consequences. J Nutr (2013) 1.09

Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc Res (2005) 1.09

Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential. Mol Nutr Food Res (2013) 1.07

Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia. Cancer Immunol Immunother (2004) 1.04

Adverse effects of free fatty acid associated with increased oxidative stress in postischemic isolated rat hearts. Mol Cell Biochem (2006) 1.03

p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid Redox Signal (2012) 1.02

NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic Biol Med (2006) 1.02

Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. J Am Coll Cardiol (2006) 1.01

Telomere length and cardiovascular disease. Arch Cardiovasc Dis (2010) 1.00

The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.98

Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases. J Cardiovasc Pharmacol (2009) 0.97

Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis (2011) 0.97

Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries. Eur Heart J Acute Cardiovasc Care (2013) 0.96

The role of RIP2 in p38 MAPK activation in the stressed heart. J Biol Chem (2008) 0.96

A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580. J Biol Chem (2009) 0.96

Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia. Am J Cardiol (2007) 0.94

Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model. Mol Cell Biochem (2006) 0.94

Outcomes after acute myocardial infarction in HIV-infected patients: analysis of data from a French nationwide hospital medical information database. Circulation (2013) 0.92